Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 4, 1999

View Archived Issues

EuropaBio Defends Industry, Proposes Centralized System

Atugen Gains U.S. Presence Via Collaboration, Subsidiary

Obesity Drugs Could Spring From Discovery Of Receptor

Biota Gets Much Of Value Back After U.S. Approval Of Relenza

CellStain Nears Full Trials Of Broad Cancer Diagnostic

Cantab Drops Vaccine Work In Chicken Pox, Shingles

Xenome Receives Investment From Medica For Pain Drug

Neurochem, Resolution Align To Detect Alzheimer's Early

UK Considers Allowing Secrecy Following Greenpeace Incident

Oxford Asymmetry Grows Despite Struggles In UK

BioLitec Moves Forward In Photodynamic Therapy

Alizyme Demonstrates Delivery To Colon Of Steroid Product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...